| Literature DB >> 27058558 |
Dalia Ponce1, Diane L Brinkman2, Jeremy Potriquet3, Jason Mulvenna4,5.
Abstract
Jellyfish venoms are rich sources of toxins designed to capture prey or deter predators, but they can also elicit harmful effects in humans. In this study, an integrated transcriptomic and proteomic approach was used to identify putative toxins and their potential role in the venom of the scyphozoan jellyfish Chrysaora fuscescens. A de novo tentacle transcriptome, containing more than 23,000 contigs, was constructed and used in proteomic analysis of C. fuscescens venom to identify potential toxins. From a total of 163 proteins identified in the venom proteome, 27 were classified as putative toxins and grouped into six protein families: proteinases, venom allergens, C-type lectins, pore-forming toxins, glycoside hydrolases and enzyme inhibitors. Other putative toxins identified in the transcriptome, but not the proteome, included additional proteinases as well as lipases and deoxyribonucleases. Sequence analysis also revealed the presence of ShKT domains in two putative venom proteins from the proteome and an additional 15 from the transcriptome, suggesting potential ion channel blockade or modulatory activities. Comparison of these potential toxins to those from other cnidarians provided insight into their possible roles in C. fuscescens venom and an overview of the diversity of potential toxin families in cnidarian venoms.Entities:
Keywords: Chrysaora; Jellyfish; nematocyst; proteome; toxin; transcriptome; venom
Mesh:
Substances:
Year: 2016 PMID: 27058558 PMCID: PMC4848628 DOI: 10.3390/toxins8040102
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1C. fuscescens jellyfish and tentacle tissue. (A) Representative adult specimen used for biological sampling. Average bell diameter of mature medusae is 25 cm and extended tentacles are approximately 1 m long. Photograph © Dalia Ponce; (B) Micrograph of the tentacle tissue used for RNA extractions and nematocyst isolation. Photograph © Dr. Diane Brinkman.
Description of de novo assembly and analysis of the C. fuscescens tentacle transcriptome.
| Assembly | Count |
|---|---|
| Raw reads (paired-end) | 26,991,925 |
| After cleaning | 17,319,746 |
| Contigs | 30,317 |
| Average length ± SD | 628.70 ± 840.07 |
| Length (min and max) | 201 to 31,945 |
| GC content | 40.42% |
| Raw reads mapped to contigs | 97.69% |
| Containing a coding region | 23,534 (78%) |
| Transcripts with significant BLAST hit (1 × 10−5) | 16,925 (72%) |
| GenBank non-redundant Cnidarian protein sequences | 15,987 (53%) |
| 14,261 (47%) | |
| SwissProt | 13,375 (44%) |
| 12,144 (40%) | |
| Uniprot animal toxin and venom | 549 (2%) |
| Returning GO term | 11,586 (49%) |
| Molecular function | 8265 (35%) |
| Biological process | 4768 (20%) |
| Cellular component | 2173 (9%) |
| Predicted proteins with signal sequences * | 1012 (4%) |
| Predicted proteins with two or more transmembrane helices | 641 (2%) |
* SignalP on top hit from SwissProt returned 1666 (7%).
Figure 2Functional annotation of transcripts with predicted coding regions. (A) Top 5 GO term hits in the categories of molecular function (MF), biological process (BP) and cellular component (CC); (B) Classification of enzymes according to Enzyme Commission (EC) number.
Figure 3Venom proteome of C. fuscescens. (A) SDS-PAGE analysis of crude venom (lanes 1 and 2). The 40 gel bands used for in-gel tryptic digestion and tandem mass spectrometry are indicated in lane 2. Molecular masses of the protein marker (M) are shown alongside in kDa; (B) Functional annotation of proteins identified in proteomics experiments.
Putative toxins and venom-related proteins identified in the C. fuscescens venom proteome using MS/MS.
| Transcript | Category | Unique Peptides ( | Coverage (%) | InterProScan Protein Feature | Signal Peptide (Yes/No) | Transmembrane Domain (Yes/No) | BLAST Analysis | |
|---|---|---|---|---|---|---|---|---|
| Protein Identity | Species of Closest Homology | |||||||
| comp13691_c0_seq2 | Metalloprotease | 18 | 76.6 | Peptidase M1, alanine aminopeptidase | n | n | Aminopeptidase N-like | |
| comp12218_c0_seq1 | Metalloprotease | 16 | 76.2 | Peptidase M13 | n | y (27–49) | Endothelin-converting enzyme 1-like | |
| comp13767_c0_seq1 | Metalloprotease | 10 | 80.4 | Peptidase M13 | y (1–29) | y (12–29) | Endothelin-converting enzyme 2-like | |
| comp11996_c0_seq1 | Metalloprotease | 8 | 62.2 | Peptidase M1, alanine aminopeptidase | n | n | Endoplasmic reticulum aminopeptidase 1-like | |
| comp11571_c0_seq2 | Metalloprotease | 8 | 75.4 | Peptidase M13 | n | n | Endothelin-converting enzyme 1-like | |
| comp10942_c1_seq1 | Metalloprotease | 7 | 71.0 | Peptidase M13 | n | y (31–53) | Endothelin-converting enzyme 1-like | |
| comp12208_c0_seq1 | Metalloprotease | 6 | 61.0 | Peptidase M14, carboxypeptidase A | y (1–20) | y (292–309) | Carboxypeptidase D-like | |
| comp9530_c0_seq2 | Metalloprotease | 6 | 87.3 | Peptidase M13 | n | n | Endothelin-converting enzyme 1-like | |
| comp14393_c0_seq1 | Metalloprotease | 5 | 68.2 | Peptidase M2, peptidyl-dipeptidase A | n | n | Angiotensin-converting enzyme-like isoform | |
| comp14137_c0_seq1 | Metalloprotease | 2 | 42.1 | Peptidase M2, peptidyl-dipeptidase A | n | n | Angiotensin-converting enzyme | |
| comp14070_c0_seq1 | Metalloprotease | 3 | 67.3 | Peptidase M18 | n | y (493–510) | Aspartyl aminopeptidase-like | |
| comp13494_c0_seq1 | Aspartyl protease | 2 | 39.6 | Aspartic peptidase | y (1–17) | y (161–193) | Cathepsin D | |
| comp12883_c0_seq1 | Aspartyl protease | 2 | 48.9 | Aspartic peptidase | y (1–18) | y (2–24) | Aspartyl protease | |
| comp13655_c0_seq2 | Serine protease | 2 | 67.8 | Peptidase S8/S53 | n | y (156–178, 323–339, 748–771) | PC3-like endoprotease variant B isoform X1 | |
| comp13207_c0_seq1 | Pore-forming toxin | 6 | 75.4 | Delta-endotoxin, | y (1–19) | y (104–125) | Toxin TX2 | |
| comp12925_c0_seq1 | Pore-forming toxin | 8 | 76.0 | Delta endotoxin, | n | y (15–37) | Uncharacterized protein LOC105843890 | |
| comp13855_c0_seq5 | Venom allergen | 37 | 83.0 | Cysteine-rich secretory protein, allergen V5/Tpx-1-related | n | n | Cell wall protein PRY3-like | |
| comp13672_c0_seq1 | Venom allergen | 18 | 81.4 | Cysteine-rich secretory protein, allergen V5/Tpx-1-related | n | n | Cell wall protein PRY3-like | |
| comp13791_c0_seq1 | Venom allergen | 15 | 75.2 | Cysteine-rich secretory protein, allergen V5/Tpx-1-related | n | n | Cell wall protein PRY3-like | |
| comp13791_c0_seq3 | Venom allergen | 9 | 70.6 | Cysteine-rich secretory protein, allergen V5/Tpx-1-related | n | n | Cell wall protein PRY3-like | |
| comp13342_c1_seq2 | Venom allergen | 2 | 76.1 | Cysteine-rich secretory protein, allergen V5/Tpx-1-related | n | n | Cell wall protein PRY3-like | |
| comp12264_c0_seq1 | Venom allergen | 2 | 81.7 | Cysteine-rich secretory protein, allergen V5/Tpx-1-related | y (1–20) | y (7–29) | PRY2-like protein | |
| comp13629_c0_seq1 | C-type lectin | 194 | 85.0 | C-type lectin | y (1–20) | y (344–362) | Golgi-associated plant pathogenesis-related protein 1 | |
| comp13792_c0_seq2 | C-type lectin | 44 | 70.0 | C-type lectin | n | y (96–116) | Golgi-associated plant pathogenesis-related protein 1 | |
| comp13880_c0_seq1 | C-type lectin | 8 | 56.5 | C-type lectin | y (1–21) | y (348–368) | Golgi-associated plant pathogenesis-related protein 1 | |
| comp13219_c0_seq1 | Glycoside hydrolase | 18 | 59.4 | Beta-hexosaminidase | y (1–20) | y (416–438) | beta-hexosaminidase subunit alpha-like isoform X1 | |
| comp7130_c0_seq1 | Enzyme inhibitor | 4 | 64.0 | Peptidase S8/S53 domain | y (1–19) | y (484–507) | Tripeptidyl-peptidase 1-like | |
Figure 4Nucleotide and deduced amino acid sequence of CfusTX-1 (GenBank accession number KU529195). The start codon (ATG) is underlined in black and the stop codon is indicated with an asterisk. A 19-residue signal peptide is underlined in orange and a predicted δ-endotoxin, N-terminal-like domain is underlined in purple. Unique peptide matches from mass spectrometry experiments are indicated in red.
BLAST homology of CfusTX-1 from C. fuscescens and pore-forming toxins from other jellyfish.
| Toxin ID | Jellyfish Species | BLAST | UniProt Accession No. | Reference | |
|---|---|---|---|---|---|
| Identity (%) | |||||
| TX2 * | 48 | 2 × 10−124 | I3VAS2 | UniProt | |
| TX1 * | 37 | 2 × 10−96 | I3VAS1 | UniProt | |
| CfTX-A | 25 | 1 × 10−27 | T1PRE3 | [ | |
| CrTX-A | 25 | 3 × 10−26 | Q9GV72 | [ | |
| CfTX-1 | 24 | 9 × 10−26 | A7L035 | [ | |
| CfTX-2 | 24 | 3 × 10−27 | A7L036 | [ | |
| CqTX-A | 24 | 9 × 10−25 | P58762 | [ | |
| CaTX-A | 24 | 1 × 10−23 | Q9GNN8 | [ | |
| CfTX-Bt | 24 | 2 × 10−16 | W0K4S7 | [ | |
| CfTX-B | 23 | 1 × 10−26 | T1PQV6 | [ | |
| MkTX-A1 * | 20 | 6 × 10−10 | D2DRC0 | [ | |
| MkTX-A2 * | 20 | 1 × 10−9 | D2DRC1 | [ | |
* Predicted proteins; 1 renamed as Carybdea brevipedalia by Toshino et al. [57]; 2 renamed as Chironex yamaguchii by Lewis and Bentlage [58]; 3 renamed as Alatina moseri by Gershwin [59].
Figure 5Partial multiple protein sequence alignment of CfusTX-1 and related jellyfish toxins highlighting the regions of highest sequence similarity. Sequences were aligned using MUSCLE and visualized using Jalview. Amino acid residue shading is based on the Clustal protein colour scheme, with color intensity increasing as residue conservation increases from 25% to 100%. Identical residues are indicated with an asterisk. Dashes represent gaps introduced for better alignment. A predicted transmembrane spanning region (TSR1) that is common among the jellyfish toxins is indicated with a black outline. A purple line above the alignment corresponds to a predicted δ-endotoxin, N-terminal-like domain. References for Aacomp182923_c1_seq1_3 [24] and AaTX-1-like [26].
Diversity of major potential toxin families identified in cnidarian venoms using transcriptomic and/or proteomic (MS/MS) analyses.
| Toxin Family | Class Scyphozoa | Class Cubozoa | Class Hydrozoa | Class Anthozoa | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proteinases | (E) Cysteine protease; (T) astacin, zinc and matrix metallo-proteinases, serine proteases; ECE-1 | (T) Zinc metallo-proteinases | (T) Zinc metallo-proteinases; ECE-1 | (T, P) Serine peptidases, zinc metallo-proteinases, ECE-1 and -2 | (T,P) Serine peptidases; astacin and zinc metallo-proteinases; (P) ECE-2 and 2-like | (E) Serine peptidases; carboxy-peptidases; metalloproteases | (E) Serine peptidases | (P) Serine peptidases; zinc metallo-proteinases | (P) Serine peptidases; zinc metallo-proteinase; (T, P) ECE-1 | (T) ECE-1 | (T) Astacin-like metallo-proteinase | (T, P) Serine peptidases; astacin and other metallo-proteinases | |
| Lipases | (E, T) PLA2; (T) PLD; LALs | (T) PLA2 and PLB1 | (T, P) PLA2 | (T) LALs; PLA2 and PLB2 | (T) LALs; PLA2 | - | - | (P) PLA2 | (E, T, P) PLA2 | - | (T) | (T, P) LALs; endothelial lipase; PLB; PLA1; PLA2 | |
| Deoxyribonu-cleases | (T) Plancitoxin-like | - | - | (T) Plancitoxin-like | - | - | - | - | (E) Plancitoxin-like | - | - | - | |
| Cytolysins | (E) Hemolysin C | (T) Hemolysins (homologues to ryncolin, veficolin, hemolysin hlyIII) | - | - | - | - | - | (P) AvTX-60A and PsTX-like | (E) Actinoporins and hydralysins | (T) Actinoporin-like | - | (T, P) Bandaporin; actinoporin; urticinatoxin | |
| Pore-forming (cnidarian toxin family) | (T) CfTX-like; (P) CcTX-1 | - | (T,P) 1 AaTX-1 and -2; CaTX-like | (T, P) CfusTX-1 | (T, P) CfTXs | (E) MkTXs (CfTX-like) | - | - | (T, P) CaTX-like | (T) CaTX-like | - | (T, P) CfTX-1-like | |
| Pore-forming (MAC-PF) | - | - | (T, P) | - | - | - | - | - | (T, P) | (T, P) | - | - | |
| CRISPs | - | - | * | (T, P) allergen V5/Tpx-1-related | (T) allergen V5/Tpx-1-related | - | - | - | (E) venom allergen 5 | * | (T) venom allergen 5 /PR-1-like | - | |
| C-type lectins | - | (T) | (T) | (T, P) | (T, P) | - | - | - | (T, P) | - | (T) | (T, P) | |
| Protease inhibitors | (T) Kazal-type; Kunitz-type | (T) Kunitz-type | (T) Kunitz-type | (T, P) Kunitz-type | (T, P) Cysteine protease inhibitors; Kunitz-type; Kazal-type | (E) Kazal-type | - | - | (T, P) Cysteine protease inhibitors; Kunitz-type | (P) Kunitz-type | - | (T, P) Kunitz-type | |
| Proteins with ShKT domains | - | (T) 1–4 domains + other protein domains | (T) 1–3 domains + other protein domains | (T) 1–4 domains + other protein domains; (P) CRISP-like protein and C-type lectin | (T, P) + astacin domains | (E) | (E) | - | (E, T, P) + metalloprotease-like protein domains | (T, P) | (T) | - | |
| Neurotoxins (modulators of nicotinic receptors or presynaptic nerve endings) | - | (T) Botulinum neurotoxins; α-latrocrusto-toxin-Lt1a | - | - | - | - | - | (P) κ-4-Bungarotoxin; α-latrocrusto-toxin-Lt1a | - | - | - | - | |
| Neurotoxins (K+ channel blockers) | - | - | - | - | - | - | - | - | (E) Kalicludine-like | (T, P) ShK toxins, BDS-like | - | - | |
| Neurotoxins (Na+ channel blockers) | - | - | - | - | - | - | - | - | (T, P) Av1, Av2 and Av3 | (T) Nv1 | (T, P) Av1-like | ||
| Associated References | [ | [ | [ | Present work | [ | [ | [ | [ | [ | [ | [ | [ | |
(E) EST library, (T) transcriptomic or (P) venom proteome analysis; 1 GenBank Accession No. AFK76348 and AFK76349; * Present but excluded as potential toxins.